Human phenotype ontology annotation and cluster analysis to unravel genetic defects in 707 cases with unexplained bleeding and platelet disorders
Sarah K. Westbury(University of Bristol), Kathleen Freson(KU Leuven), Ernest Turro(University of Cambridge), Tadbir K. Bariana(Royal Free London NHS Foundation Trust), Willem H. Ouwehand(NHS Blood and Transplant), Harald Schulze, Stuart Meacham(National Health Service), Wendy N. Erber(The University of Western Australia), Alan T. Nurden(Hôpital Xavier Arnozan), Andrew Mumford(University of Bristol), Xavier Pillois(Electrophysiology and Heart Modeling Institute), Pawan Poudel(National Health Service), Peter N. Robinson(Max Planck Institute for Molecular Genetics), Keith Gomez(Royal Free London NHS Foundation Trust), Michele P. Lambert(Children's Hospital of Philadelphia), Antony Attwood(Wellcome Sanger Institute), Michael Laffan(Hammersmith Hospital), Paquita Nurden(Plateforme Technologique d'Innovation Biomédicale), Sol Schulman(Beth Israel Deaconess Medical Center), Augusto Rendon(University of Cambridge), Abi Crisp-Hihn(NHS Blood and Transplant), Ri Liesner(Goshen College), Claire Lentaigne(Hammersmith Hospital), Chris Van Geet(KU Leuven), Sjoert B.G. Jansen(National Health Service), Kathelijne Peerlinck(KU Leuven), Jonathan Stephens(NHS Blood and Transplant), Bruce Furie(Beth Israel Deaconess Medical Center), Michael Gattens(National Health Service), Anne M. Kelly(National Health Service), Daniel Greene(University of Cambridge), Carolyn M. Millar(National Health Service), Sylvia Richardson(Hammersmith Hospital), Steve Austin(National Health Service), Tamam Bakchoul(Universitätsmedizin Greifswald), Jennifer D. Jolley(University of Cambridge), Nicola Foad(National Health Service), Ilenia Simeoni(University of Cambridge), David J. Perry(National Health Service), Rémi Favier(Inserm)
Cited by 125
Related Papers
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
|Nature|2007|9.6k
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
|The Lancet|2005|3.4k